NEW APPROACH TO MANAGEMENT OF MALIGNANT ASCITES WITH A STREPTOCOCCAL PREPARATION, OK-432 .1. IMPROVEMENT OF HOST IMMUNITY AND PROLONGATION OF SURVIVAL

This publication has 7 references indexed in Scilit:

• Clinical studies on cell-mediated immunity in patients with malignant disease I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsivenessin vitro
  Cancer, 1980
• STUDIES ON THE IMMUNOPOTENTIATING EFFECTS OF A STREPTOCOCCAL PREPARATION, OK-432 .1. ENHANCEMENT OF T-CELL-MEDIATED IMMUNE-RESPONSES OF MICE
  1979
• Intracavitary bleomycin in the management of malignant effusions
  Cancer, 1976
• Immunochemotherapy in human lung cancer using the streptococcal agent OK-432
  Cancer, 1976
• Intracavitary 5-Fluorouracil in Malignant Effusions
  Archives of internal medicine (1960), 1965
• EXPERIMENTAL ANTICANCER STUDIES .21. EFFECT OF PENICILLIN TREATMENT OF HEMOLYTIC STREPTOCOCCUS ON ITS ANTICANCER ACTIVITY
  1964
• DIRECT INSTILLATION OF NITROGEN MUSTARD IN THE MANAGEMENT OF MALIGNANT EFFUSIONS
  Annals of the New York Academy of Sciences, 1958